use
bacteria
virus
toxin
intent
caus
infect
realist
threat
predomin
caus
concern
rapid
infect
difficulti
diagnosi
treat
pneumon
diseas
concern
highlight
inhal
infect
postal
worker
us
bacillu
anthraci
endospor
rang
biothreat
agent
pose
threat
requir
utilis
rang
differ
convent
therapeut
bacteria
virus
requir
treatment
antibiot
antivir
compound
respect
whilst
toxin
requir
treatment
specif
antisera
variou
issu
concern
use
avail
convent
treatment
biothreat
agent
resist
antibiot
may
natur
acquir
engin
antivir
compound
limit
avail
due
increas
toxic
issu
aris
common
target
host
cell
viru
furthermor
vaccin
unavail
way
licensur
therefor
prudent
research
novel
therapeut
combat
spectr
intent
releas
biothreat
agent
initi
step
infect
pathogen
toxin
involv
interact
host
cell
gener
via
bind
adhesin
carbohydr
receptor
cell
surfac
via
multival
interact
fig
interact
prevent
microbi
remov
physic
clearanc
mechan
host
epitheli
surfac
eg
airflow
mucociliari
clearanc
respiratori
tract
carbohydr
receptor
take
form
rel
short
chain
saccharid
unit
known
oligosaccharid
divers
monosaccharid
unit
linkag
branch
pattern
increas
complex
oligosaccharid
enabl
fulfil
rang
biolog
function
oligosaccharid
chain
link
protein
lipid
form
glycoprotein
glycolipid
insert
host
cytoplasm
membran
oligosaccharid
chain
face
extern
milieu
rang
glycoconjug
locat
intact
abrad
host
cell
surfac
may
use
pathogen
attach
tabl
carbohydr
recognit
import
function
innat
immun
system
free
oligosaccharid
present
bodi
fluid
mucu
breast
milk
propos
prevent
attach
epitheli
cell
surfac
furthermor
number
protein
involv
innat
immun
mannosebind
lectin
surfact
protein
dendrit
cellspecif
intercellular
adhes
molecul
nonintegrin
dcsign
liverlymph
nodespecif
intercellular
adhes
molecul
nonintegrin
lsign
ficolin
possess
carbohydr
recognit
domain
crd
specif
oligosaccharid
chain
present
capsul
lp
glycoprotein
microbi
pathogen
util
oligosaccharid
inhibit
bacteri
attach
prove
success
number
pathogen
vitro
vivo
includ
streptococcu
pneumonia
helicobact
pylori
pseudomona
aeruginosa
legionella
pneumophila
microbi
attach
offer
attract
point
intervent
process
infect
number
method
use
determin
bind
moieti
microorgan
toxin
includ
thinlay
chromatographi
tlc
solidphas
competit
bind
assay
lectin
bind
surfac
plasmon
reson
spr
specif
adhesinoligosaccharid
interact
influenc
determin
pathogen
host
rang
tropism
variou
cell
type
major
pathogen
toxin
use
biothreat
agent
would
dissemin
aerosol
specter
intent
releas
pathogen
microb
toxin
real
threat
articl
review
literatur
adhesin
biothreat
agent
interact
oligosaccharid
potenti
antiadhes
compound
altern
convent
therapeut
minim
bind
structur
ricin
well
characteris
offer
best
candid
success
antiadhes
therapi
base
structur
botulinum
toxin
serotyp
af
bind
low
number
gangliosid
henc
possibl
determin
minim
structur
bind
minim
disaccharid
sequenc
found
gangliosid
requir
adhes
mani
respiratori
pathogen
although
number
adhesin
identifi
bacteri
biothreat
agent
yersinia
pesti
bacillu
anthraci
francisella
tularensi
brucella
speci
burkholderia
pseudomallei
specif
inform
regard
vivo
express
pneumon
infect
lack
limit
oligosaccharid
inhibit
studi
indic
potenti
hydrophob
compound
paranitrophenol
start
point
ration
design
gener
antiadhes
compound
cocktail
multival
oligosaccharid
base
minim
bind
structur
identifi
adhesin
would
offer
best
candid
antiadhes
therapi
surfac
pathogen
adhesin
toxin
host
respiratori
tract
epitheli
cell
immun
cell
ie
alveolar
macrophag
wide
varieti
oligosaccharid
structur
express
respiratori
tract
epithelium
mucin
associ
mucu
bilay
furthermor
physiolog
statu
host
cell
epithelium
affect
type
quantiti
surfaceexpress
oligosaccharid
cellular
differenti
injuri
repair
respiratori
epitheli
cell
lead
increas
gangliosid
eg
exposur
proteoglycan
constitu
extracellular
matrix
eg
collagen
fibronectin
laminin
heparan
sulphat
chondroitin
sulphat
express
neuraminidas
glycosidas
pathogen
eg
p
aeruginosa
pneumonia
influenza
viru
result
desialyl
sialic
acid
residu
glycolipid
glycoprotein
subsequ
present
receptor
attach
quantiti
express
vari
accord
particular
respiratori
epitheli
cell
line
use
adhes
assay
varianc
host
cell
oligosaccharid
profil
affect
rel
bind
pathogen
henc
tropism
particular
cell
tissu
type
also
repres
disadvantag
use
anim
model
may
express
tissu
glycoconjug
profil
human
henc
initi
deposit
respiratori
tract
therefor
success
therapeut
use
oligosaccharid
pathogen
would
requir
inhibit
adhes
anatom
region
commentari
aim
review
current
situat
oligosaccharidepathogen
interact
specif
focu
pathogen
concern
biothreat
perspect
assess
potenti
oligosaccharid
mimic
develop
novel
antiadhes
therapeut
intent
use
biothreat
agent
like
involv
dissemin
aerosol
result
inhal
pneumon
present
diseas
deposit
inhal
droplet
carri
pathogen
within
anatom
region
mammalian
respiratori
tract
nasopharyng
tracheobronchi
pulmonari
depend
droplet
size
therefor
depend
droplet
size
gener
intent
natur
dissemin
deposit
henc
attach
may
occur
nasal
passag
alveoli
pneumon
infect
opportun
therapeut
intervent
antiadhes
compound
occur
molecular
determin
attach
phagocytosi
engulf
express
clinic
trial
use
antiadhes
therapeut
success
antiadhes
therapi
depend
pharmacokinet
pharmacodynam
properti
compound
within
bodi
small
number
clinic
trial
perform
antiadhes
oligosaccharid
clinic
trial
use
g
per
day
sialyllactos
deliv
oral
prevent
infect
h
pylori
prove
unsuccess
similarli
phase
ii
clinic
trial
intranas
administr
children
reduc
incid
pneumonia
h
influenza
nasopharyng
carriag
otiti
media
lack
success
clinic
trial
may
due
combin
enzymat
degrad
express
multipl
receptor
pathogen
addit
differ
occur
express
host
cell
glycoconjug
adult
infant
may
explain
difficulti
studi
ukkonen
et
al
initi
screen
base
epitheli
cell
obtain
upper
respiratori
tract
adult
support
success
local
administr
mixtur
monosaccharid
henc
vivo
trial
may
repres
particularli
pathogen
hostspecif
human
success
antiadhes
therapi
biothreat
agent
requir
consider
particular
adhesinligand
interact
must
inhibit
within
specif
physiolog
anatomi
respiratori
tract
furthermor
case
bacteria
adhesin
express
regul
paramet
temperatur
therefor
specif
tissu
tropism
may
alway
occur
due
lack
express
phenomenon
phase
variat
phenotyp
switch
number
respiratori
pathogen
shown
attach
oligosaccharid
structur
tabl
minim
disaccharid
sequenc
found
gangliosid
requir
adhes
mani
respiratori
pathogen
examin
broad
spectrum
pathogen
use
base
disaccharid
unit
would
appear
cast
candid
worthi
explor
novel
gener
antiadhes
therapeut
furthermor
pathogen
express
oligosaccharid
structur
form
capsul
lp
glycoprotein
may
play
role
attach
surfac
host
epitheli
immun
cell
tabl
inexhaust
list
glycoconjug
structur
use
identifi
bind
moieti
microorgan
bind
respiratori
tract
structur
lewi
x
antigen
glcnac
heparin
n
n
n
n
repeat
variabl
disaccharid
unit
sulphat
variabl
chondroitin
sulphat
n
sulphat
variabl
posit
quantiti
cer
ceramid
fuc
fucos
gal
galactos
galnac
nacetylgalactosamin
glc
glucos
glca
glucuron
acid
glcnac
nacetylglucosamin
glcn
nsulphat
glucosamin
idoa
iduron
acid
idoa
sulphat
iduron
acid
neuac
nacetylneuramin
acid
sialic
acid
legionella
pneumophila
heparin
moraxella
cattarhali
mycoplasma
pneumonia
gal
dextran
sulphat
heparin
mannos
neisseria
meningitidi
lewi
fibronectin
gangliosid
laminin
vitronectin
collagen
iv
yersinia
pesti
collagen
laminin
saccharid
particularli
monoval
compound
may
suffer
due
degrad
host
enzym
physiolog
condit
could
lead
requir
excess
potenti
toxic
level
inhibit
pathogen
attach
furthermor
polar
size
multival
inhibitor
could
lead
problem
vivo
use
issu
may
allevi
degre
concept
use
particular
therapeut
exampl
topic
applic
therapeut
skin
epithelium
respiratori
tract
less
like
experi
problem
enzymat
degrad
experienc
gastrointestin
tract
oral
deliveri
lack
immun
toler
system
deliveri
biothreat
agent
may
bacteri
viral
fungal
repres
specif
toxin
howev
share
characterist
elicit
diseas
toxic
via
inhal
major
case
littl
known
regard
mechan
attach
immun
cell
epithelium
respiratori
tract
list
known
adhesin
biothreat
agent
present
tabl
b
anthraci
archetyp
biothreat
agent
adhes
inhal
endospor
involv
interact
exterior
endospor
surfaceexpress
compon
human
respiratori
tissu
littl
known
regard
mechan
attach
endospor
veget
cell
endospor
possess
extern
exosporium
compris
hexagon
lattic
protrud
filament
appendag
glycoprotein
may
mediat
attach
promot
intern
macrophag
germin
veget
cell
express
rang
put
known
adhesin
may
promot
attach
host
cell
includ
slayer
protein
sap
bsla
teichoic
acid
collagenand
fibronectinbind
protein
acid
capsul
inhibit
attach
veget
cell
doublecur
strain
cell
line
use
oligosaccharid
greatest
case
dextran
sulphat
adhes
mediat
bsla
slayer
protein
capsul
encod
absent
f
tularensi
clinic
present
rang
manifest
howev
seriou
pneumon
infect
recent
cellsurfac
associ
adhesin
identifi
type
iv
pili
apparatu
encod
pilf
pilt
gene
mediat
adher
cultur
macrophag
pneumocyt
hepatocyt
cell
line
fsap
surfac
express
protein
adhes
properti
toward
type
ii
pneumocyt
cell
line
f
tularensi
pilin
structur
subunit
pila
capabl
express
type
iv
pili
within
neisseria
gonorrhoea
mutant
lack
gene
type
iv
pilu
express
partial
restor
compet
natur
genet
transform
observ
n
gonorrhaea
mutant
express
f
tularensi
pila
gene
import
type
iv
pili
demonstr
vivo
respect
intraderm
infect
howev
impact
galactos
mannos
nacetylneuramin
acid
specif
pai
paii
adhesin
p
aeruginosa
treat
otiti
externa
although
recoveri
slower
patient
receiv
gentamicin
like
use
multival
inhibitor
oligosaccharid
base
monosaccharid
unit
would
even
success
select
pressur
use
convent
bactericid
virucid
antimicrobi
agent
aggress
regimen
exert
select
pressur
pathogen
drive
gener
resist
phenotyp
antiadhes
therapi
would
safer
gentler
therapi
ecolog
sound
ad
benefit
reduc
select
pressur
pathogen
prevent
attach
host
cell
rather
kill
noninfect
pathogen
would
remov
natur
physic
immunolog
clearanc
mechan
host
mutat
adhesin
plausibl
scenario
antiadhes
therapi
howev
oligosaccharid
inhibitor
base
ident
bind
event
pathogen
natur
adhes
process
mutat
gener
result
reduc
bind
affin
henc
less
infecti
compar
wildtyp
howev
potenti
exist
alter
tropism
tissu
could
gener
altern
problem
benefit
unlik
lytic
antibiot
antiadhes
compound
bactericid
would
gener
toxic
byproduct
eg
lp
result
bacteri
death
antiadhes
therapi
may
also
complement
tradit
antibiot
therapi
reduc
inher
resist
phenotyp
associ
attach
tissu
biofilm
receptor
redund
appar
literatur
although
moieti
make
consist
appear
minim
saccharid
sequenc
requir
pathogen
bind
inhibit
never
indic
multipl
receptor
bind
either
differ
oligosaccharid
moieti
requir
attach
repres
major
drawback
antiadhes
therapi
issu
multipl
receptorligand
interact
highlight
number
bacteri
speci
tabl
bind
rang
glycoconjug
even
high
affin
inhibitor
found
synthesis
unlik
one
singl
compound
inhibit
attach
singl
pathogen
let
alon
wide
rang
pathogen
issu
receptor
redund
less
like
issu
virus
number
adhesin
present
surfac
far
fewer
bacteria
due
code
potenti
respect
genom
materi
therefor
even
singl
pathogen
certainli
rang
respiratori
tract
pathogen
cocktail
inhibitor
would
requir
cover
rang
adhesinligand
interact
result
attach
pathogen
howev
less
like
issu
virus
toxin
bind
base
one
two
adhesinligand
interact
storag
deliveri
administr
issu
success
use
therapeut
oligosaccharid
reli
effici
storag
deliveri
advantag
oligosaccharid
proteinbas
vaccin
inher
physic
chemic
properti
oligosaccharid
highli
watersolubl
stabl
heat
alcohol
without
loss
activ
prophylact
treatment
microbi
infect
similarli
oligosaccharid
inhibitor
base
interact
spice
sulphat
ligand
may
offer
novel
therapeut
prevent
orthopoxviru
induc
complement
inactiv
rang
tissu
infect
variola
would
indic
addit
adhesin
express
initi
attach
invas
host
cell
alphaviru
veev
infect
equin
speci
howev
also
transmit
human
infect
mosquito
caus
enceph
veev
also
transmit
via
aerosol
droplet
produc
similar
diseas
symptom
initi
flulik
symptom
follow
acut
enceph
sever
case
glycoprotein
initi
attach
host
cell
studi
characteris
receptor
specif
glycoprotein
howev
known
bind
heparin
lamininbind
protein
chines
hamster
ovari
cho
mosquito
cell
line
respect
attach
bwjm
murin
macrophag
cell
line
inhibit
lectin
wheat
germ
agglutinin
concanavalin
soybean
agglutinin
indic
specif
veev
vaccin
strain
termin
residu
nacetylglucosamin
mannos
nacetylgalactosamin
respect
oligosaccharid
antiadhes
compound
yersinia
pesti
pesti
aetiolog
agent
bubon
plagu
also
caus
pneumon
infect
inhal
aerosol
invari
fatal
diseas
mortal
approach
without
therapeut
intervent
within
h
number
adhesin
identifi
although
differenti
express
profil
bubon
pneumon
form
plagu
ligand
necessarili
investig
tabl
evid
pesti
attach
oligosaccharid
includ
reduc
attach
host
cell
express
reduc
level
oligosaccharid
due
inhibit
carbohydr
biosynthesi
tunicamycin
competit
bind
assay
tlc
bind
assay
inhibitori
effect
antiadhes
compound
toward
pesti
attach
respiratori
epitheli
macrophag
cell
line
investig
inhibit
adhesin
vivo
virul
pneumon
infect
model
target
ligand
remain
unknown
furthermor
attach
invas
opsonis
nonopson
f
tularensi
macrophag
dendrit
cell
monocyt
mediat
interact
lectin
innat
immun
system
includ
mannosebind
lectin
surfact
protein
brucella
speci
infect
varieti
anim
speci
includ
sheep
pig
transmiss
human
occur
contact
infect
anim
contamin
product
milk
placent
tissu
brucella
speci
also
transmit
aerosol
rout
produc
primari
pneumonia
b
melitensi
b
abortu
bind
sialic
acid
residu
erythrocyt
macrophag
epitheli
cell
via
two
surfaceexpress
protein
identifi
adhesin
ugpb
inhibit
attach
erythrocyt
achiev
use
nacetylneuramin
acid
nacetylneuraminyl
lactos
glycosaminoglycan
chondroitin
sulphat
howev
yet
effect
vivo
determin
prophylact
administr
antiadhes
compound
may
provid
altern
support
therapi
convent
treatment
review
focu
detail
biothreat
agent
research
characterist
cellular
attach
andor
suitabl
antiadhes
therapi
investig
detail
name
pesti
b
pseudomallei
viral
agent
toxin
botulinum
toxin
ricin
staphylococc
enterotoxin
b
attach
inhibit
virus
viral
agent
venezuelan
equin
enceph
viru
veev
filovirus
ebola
marburg
possess
glycoprotein
spike
mediat
attach
host
cell
olink
oligomannos
glycan
ebola
marburg
virus
bind
crd
ctype
lectin
dcsign
lsign
found
dendrit
cell
lymph
node
cell
respect
lsign
also
express
surfac
endotheli
hepat
cell
crd
dcsign
bind
man
glcnac
oligosaccharid
affin
mannos
furthermor
mannosebind
lectin
inhibit
interact
dcsign
dendrit
cell
bind
glycoprotein
ebola
marburg
virus
ebola
marburg
virus
attach
rang
cell
type
use
folat
competit
dosedepend
inhibit
achiev
use
monoclon
antibodi
folic
acid
potenti
oligosaccharid
use
attach
inhibitor
filovirus
demonstr
inhibit
infect
hela
cell
glycodendrim
contain
thirtytwo
mannos
residu
infect
pseudotyp
lentiviru
express
ebola
glycoprotein
demonstr
dosedepend
inhibit
infect
ic
nm
mm
obtain
multival
oligomannos
glycodendrim
monosaccharid
respect
orthopoxvirus
includ
variola
smallpox
monkeypox
vaccinia
express
enzym
inactiv
complement
activ
pathway
host
smallpox
inhibitor
complement
enzym
spice
attach
host
cell
via
glycosaminoglycan
proteoglycan
includ
heparin
chondroitin
sulphat
increas
inhibitori
activ
toward
complement
degre
sulphat
influenc
bind
greatest
tabl
oligosaccharidebas
receptor
toxin
concern
biowarfar
perspect
adhes
burkholderia
pseudomallei
respiratori
cell
line
b
pseudomallei
natur
resist
rang
convent
antibiot
due
combin
multidrug
efflux
pump
mutat
enzym
target
intracellular
nich
caus
agent
melioidosi
encompass
wide
clinic
diseas
spectrum
one
manifest
pulmonari
infect
b
pseudomallei
wide
tissu
tropism
demonstr
abil
attach
rang
epitheli
cell
type
deriv
alveolar
bronchial
nasal
laryng
oral
conjunctiv
cervic
tissu
attach
depend
growth
temperatur
increas
adher
compar
b
pseudomallei
attach
human
pharyng
epitheli
cell
mediat
lesser
extent
furthermor
determin
acid
phosphatas
deriv
b
pseudomallei
possess
abil
bind
b
pseudomallei
attach
human
alveolar
pneumocyt
type
ii
cell
line
inhibit
use
rang
oligosaccharid
includ
moieti
present
type
iv
pili
encod
structur
pila
gene
identifi
b
pseudomallei
contribut
attach
virul
interestingli
pila
transcript
vari
strain
associ
differ
microcoloni
format
adhes
temperaturedepend
manner
howev
date
specif
type
iv
pilu
adhesin
determin
oligosaccharid
bind
target
toxin
number
biolog
deriv
toxin
consid
concern
biothreat
perspect
includ
botulinum
toxin
bottx
staphylococc
enterotoxin
b
seb
ricin
demonstr
bind
glycoconjug
tabl
bottx
produc
clostridium
botulinum
one
deadliest
toxin
known
bottx
inhibit
neurotransmitt
releas
prevent
normal
neuron
action
seven
differ
immunolog
type
produc
bottx
ag
requir
bind
complex
proteinac
eg
synaptotagmin
gangliosid
phospholipid
receptor
locat
neuron
presynapt
membran
elicit
action
evid
indic
differ
serotyp
bottx
interact
serotyp
specif
compon
neuron
cell
membran
tabl
appear
presenc
gangliosid
bind
requir
bottx
activ
bind
protein
receptor
alon
elicit
toxic
except
bottx
type
g
furthermor
shown
inhibit
activ
bottx
manner
independ
serotyp
affin
bottx
bind
gangliosid
differ
exampl
bottx
type
bind
preferenti
bind
also
observ
bind
deriv
castor
bean
ricini
communi
ricin
toxin
exhibit
toxic
upon
inhal
ingest
compos
two
subunit
subunit
inhibit
protein
synthesi
access
cytoplasm
target
cell
gain
whilst
b
subunit
possess
three
galactos
bind
site
elicit
attach
glycoconjug
contain
galactos
residu
ricin
display
prefer
residu
high
affin
differ
accord
cell
line
examin
situat
previous
report
ps
aeruginosa
greatest
effect
test
antiadhes
compound
pesti
adhes
observ
toward
nasal
epitheli
cell
line
best
inhibitor
pesti
attach
cell
line
examin
hydrophob
compound
paranitrophenol
inhibit
howev
specif
observ
disaccharid
inhibit
rang
depend
cell
line
moieti
present
demonstr
bind
psaa
ph
antigen
pesti
psaa
form
fimbrial
structur
low
ph
condit
mammalian
bodi
temperatur
addit
permit
bind
phosphatidylcholin
cell
surfact
lipid
moieti
plasma
apolipoprotein
b
fc
receptor
igg
isotyp
psaamedi
bind
respiratori
tract
epitheli
cell
inhibit
intracellular
uptak
howev
psaa
requir
attach
macrophag
cell
line
addit
adhesin
psaa
involv
attach
respiratori
epitheli
cell
indic
abil
doubl
mutant
adher
invad
cell
line
inde
two
homolog
heca
identifi
put
adhesin
pesti
genom
tad
gene
cluster
confer
nonspecif
adher
actinobacillu
actinomycetemcomitan
conserv
pesti
genom
yapc
autotransport
recent
describ
adhesin
although
ligand
yet
undetermin
autotransport
adhesin
yape
requir
colonis
lymph
node
subsequ
dissemin
bubon
form
effect
pneumon
infect
unknown
howev
demonstr
yape
mediat
adhes
type
ii
pneumocyt
impli
function
pulmonari
diseas
lp
pesti
interact
lectin
dcsign
locat
surfac
profession
antigenpres
cell
dendrit
cell
alveolar
macrophag
promot
phagocytosi
subsequ
transport
lymph
node
plasminogen
activ
pla
pesti
multifunct
surfac
express
protein
pla
enzymat
convert
plasminogen
plasmin
induc
degrad
fibrin
extracellular
matrix
promot
dissemin
pesti
initi
site
infect
evid
report
pla
adhesin
pesti
kim
lack
ppcp
encod
pla
demonstr
reduc
bind
certain
glycoconjug
compon
cell
membran
basement
membran
extracellular
matrix
bind
laminin
five
time
greater
observ
heparan
sulphat
whilst
littl
attach
observ
chondroitin
sulphat
fibronectin
collagen
bind
also
observ
glycolipid
lactosylceramid
globosid
collagen
bind
specif
collagen
iv
pla
interact
specif
galactos
moieti
indic
reduc
bind
collagen
iv
host
cell
galactosidas
treatment
despit
fact
number
direct
interact
host
cell
pesti
known
current
specif
role
express
protein
relat
clinic
spectrum
diseas
unknown
particularli
respect
pneumon
plagu
ration
design
oligosaccharid
inhibitor
requir
threedimension
knowledg
ie
crystal
structur
specif
adhesin
tempor
express
infect
respiratori
tract
minim
saccharid
moieti
bind
may
differ
anatom
level
depend
whether
deposit
occur
nasopharyng
tracheobronchi
pulmonari
region
respiratori
tract
even
within
anatom
region
differ
adhes
profil
may
occur
cellular
level
due
interact
specif
cell
type
multival
inhibitor
creat
attach
oligosaccharid
proteinac
scaffold
human
serum
albumin
gener
larg
glycodendrim
structur
termin
saccharid
moieti
abrog
advantag
low
molecular
weight
oligosaccharid
increas
immunogen
glycoconjug
potenti
advers
immun
respons
issu
circumv
design
dendrim
scaffold
polyamido
amin
pamam
biocompat
vivo
use
difficulti
exist
chemic
synthesi
oligosaccharid
due
necess
sequenti
protect
deprotect
reactiv
hydroxyl
group
locat
saccharid
unit
link
scientif
technolog
progress
carbohydr
research
sped
synthet
process
saccharid
chain
trisaccharid
advanc
expect
futur
current
milligram
gram
quantiti
may
synthes
rel
easili
howev
larg
scale
synthesi
relev
oligosaccharid
requir
gener
quantiti
need
treat
popul
dose
regimen
like
last
number
day
multival
inhibitor
valu
multival
design
adhes
inhibitor
demonstr
number
studi
increas
valenc
cluster
significantli
increas
inhibit
erythrocyt
haemagglutin
via
type
fimbria
e
coli
howev
increas
valenc
past
cluster
three
increas
inhibit
potenc
moieti
present
e
coli
pseudomona
aeruginosa
significantli
increas
dival
tetraval
inhibitor
inde
potenc
vari
spacer
length
two
moieti
present
dival
inhibitor
shorter
linker
arm
potent
indic
consider
ration
design
antiadhes
inhibitor
similarli
multival
inhibitor
ration
design
toxin
shigalik
toxin
e
coli
shigella
dysenteria
contain
singl
enzymat
subunit
attach
homopentamer
b
subunit
recogn
glycolipid
gb
locat
host
cell
b
subunit
contain
three
bind
site
equat
total
fifteen
bind
site
gb
toxin
howev
sitedirect
mutagenesi
b
subunit
reveal
first
two
bind
site
subunit
import
bind
permit
construct
fivearm
starfish
inhibitor
arm
possess
two
tether
saccharid
allow
decamer
present
toxin
result
fold
increas
inhibit
compar
monoval
trisaccharid
henc
due
higher
bind
affin
multival
oligosaccharid
highli
branch
glycan
contain
structur
presenc
linkag
appear
import
evidenc
significantli
weaker
bind
ricin
synthet
galactosyl
lipid
compar
lactosyl
lipid
inde
specif
two
major
bind
site
ricin
b
chain
characteris
respect
electrostat
van
der
waal
interact
energi
rang
monosaccharid
disaccharid
greatest
interact
energi
bind
site
obtain
respect
biantennari
oligosaccharid
two
termin
moieti
bind
ricin
b
chain
higher
associ
constant
disaccharid
due
bival
increas
affin
due
interact
termin
bival
galactos
residu
bind
site
addit
influenc
hydrophob
interact
hydrogen
bond
saccharid
residu
away
terminu
molar
basi
polyllysinebas
dendrim
contain
termin
galactos
unit
unit
per
mole
time
better
inhibit
ricin
bind
immobilis
asialofetuin
compar
galactos
monosaccharid
howev
number
galactos
unit
per
mole
consid
multival
dendrim
time
potent
monosaccharid
seb
produc
sever
diarrhoea
ingest
howev
also
aerosol
produc
respiratori
distress
neutral
glycosphingolipid
deriv
human
kidney
proxim
tubul
cell
demonstr
dosedepend
inhibit
seb
cell
line
analysi
reveal
receptor
digalactosylceramid
neuraminidas
treatment
fertil
trout
egg
membran
reduc
seb
bind
indic
prefer
glyconjug
contain
sialic
acid
although
specif
natur
glycoconjug
involv
remain
unidentifi
addit
seb
bind
human
monocyt
via
lewi
antigen
although
one
bind
moieti
identifi
recognis
toxin
potenti
exist
util
specif
oligosaccharid
structur
therapeut
either
individu
mixtur
provid
gener
coverag
bind
monoval
oligosaccharid
receptor
low
affin
interact
rang
perhap
unsurpris
situat
natur
pathogen
adhesin
ligand
mammalian
cell
surfac
much
stronger
due
presenc
multipl
receptorligand
interact
produc
socal
velcro
effect
highlight
increas
potenc
sialyl
oligosaccharid
inhibit
adhes
pneumonia
cultur
cell
coval
attach
human
serum
albumin
creat
multival
interact
research
focuss
attempt
increas
bind
affin
henc
increas
potenti
oligosaccharid
use
antiadhes
compound
product
multival
oligosaccharid
compound
structur
modif
base
oligosaccharid
two
method
potenti
increas
bind
affin
adhesin
chemic
composit
substitut
group
appear
due
physic
distribut
group
along
polymer
glucos
backbon
dextran
modifi
variant
base
disaccharid
galactosucros
demonstr
util
approach
pesti
particular
compound
highli
neg
charg
due
substitut
galactosucros
hydroxyl
group
chlorosulph
chlorin
group
demonstr
significantli
better
level
inhibit
compar
galactosucros
best
galactosucros
variant
averag
inhibit
across
cell
line
due
substitut
hydroxyl
hydrophob
benzyl
group
appear
charg
hydrophob
interact
could
play
import
role
adhesinoligosaccharid
interact
pesti
would
interest
assess
situat
base
saccharid
close
resembl
known
ligand
use
pesti
attach
exampl
provid
evid
ration
structur
modif
minim
saccharid
structur
requir
adhesin
bind
could
increas
bind
affin
offer
candid
antiadhes
therapi
hydrophob
interact
hydrophob
interact
van
der
waal
forc
play
critic
role
initi
nonspecif
adhes
host
cell
prior
higher
affin
specif
interact
hydrophob
interact
also
play
role
specif
bind
indic
express
hydrophobin
surfac
bacteri
cell
interact
hydrophob
moieti
interact
pak
pilu
adhesin
p
aeruginosa
driven
hydrophob
forc
role
hydrophob
adhesinsaccharid
interact
highlight
antiadhes
characterist
hydrophob
aromat
compound
high
level
inhibit
e
coli
attach
vagin
epitheli
cell
achiev
compound
includ
paranitrophenol
paraansidin
dltyrosin
monosaccharid
substitut
aminophenyl
nitrophenol
group
inde
except
b
anthraci
success
compound
test
inhibitor
use
lower
concentr
achiev
similar
level
inhibit
attach
monoval
counterpart
may
increas
therapeut
potenti
oligosaccharid
vivo
structur
modif
saccharid
moieti
bind
affin
adhesinoligosaccharid
interact
alter
structur
modif
oligosaccharid
exampl
halogen
sulphat
methyl
acetyl
benzyl
approach
requir
knowledg
minim
saccharid
sequenc
requir
attach
chang
size
charg
base
unit
affect
good
fit
adhesin
ligand
exampl
bind
specif
pilu
adhesin
p
aeruginosa
pak
analyz
modif
specif
hydroxyl
acetamido
group
disaccharid
hydroxyl
group
substitut
omethyl
opropyl
group
whilst
acetamido
group
chang
propionamido
group
analog
substitut
increas
bind
affin
pili
increas
hydrophob
substitut
hydroxyl
group
galactos
differ
length
side
chain
may
gener
better
inhibitor
increas
bind
affin
enabl
therapeut
intervent
p
aeruginosa
infect
vivo
charg
often
play
critic
role
interact
adhesin
oligosaccharid
moieti
role
charg
adhesinoligosaccharid
interact
chlamydia
trachomati
demonstr
use
sulphat
polyanion
compound
increas
neg
charg
due
possess
one
sulphat
group
per
disaccharid
unit
best
inhibitor
deriv
dextran
possess
variou
percentag
carboxymethyl
benzylamid
sulphon
group
differ
abil
inhibit
attach
rang
virus
includ
respiratori
syncyti
viru
rsv
herp
simplex
virus
hsv
human
cytomegaloviru
hcmv
human
immunodefici
viru
hiv
composit
profoundli
affect
inhibitori
activ
activ
hsv
depend
dextran
contain
high
percentag
benzylamid
sulphon
substitut
contrast
activ
derivatis
dextran
rsv
hcmv
hiv
influenc
juic
also
demonstr
inhibit
attach
dental
cari
caus
oral
bacteria
polymer
proanthocyanidin
deriv
south
african
geranium
pelargonium
sidioid
significantli
reduc
adhes
h
pylori
section
human
gastric
mucosa
addit
proanthocyanidin
cranberri
juic
also
contain
nondialys
high
molecular
weight
materi
significantli
reduc
attach
infect
influenza
viru
type
b
madinedarbi
canin
kidney
mdck
cell
inhibit
sialic
acidspecif
haemagglutinin
potenti
compound
inhibit
attach
respiratori
tract
pathogen
determin
pathogen
toxin
includ
biothreat
concern
requir
attach
host
cell
usual
via
adhesinoligosaccharid
interact
invad
caus
diseas
lend
credenc
potenti
utilis
receptor
analogu
therapeut
intervent
howev
review
highlight
rel
littl
known
regard
adhesin
express
mani
pathogen
may
utilis
biothreat
situat
furthermor
even
less
known
regard
express
locat
respiratori
tract
initi
interact
host
epithelium
occur
inhal
aerosolis
pathogen
inform
respiratori
epitheli
glycom
human
anim
model
urgent
requir
enabl
effici
target
antiadhes
therapeut
furthermor
focu
entir
respiratori
epitheli
surfac
pathogen
interact
may
occur
ie
lower
upper
respiratori
tract
would
benefici
due
kinet
particl
deposit
inhal
lead
potenti
multipl
site
initi
interact
clinic
practic
use
antiadhes
compound
stall
due
limit
success
clinic
trial
howev
futur
dictat
advanc
identif
specif
adhesinoligosaccharid
interact
pathogen
host
cell
respiratori
tract
use
divers
techniqu
molecular
biolog
comput
model
xray
crystallographi
enabl
direct
synthesi
ration
design
oligosaccharid
increas
bind
affin
advanc
result
identif
better
lead
compound
antiadhes
therapi
vivo
rang
bacteria
infect
respiratori
tract
paranitrophenol
indic
gener
natur
hydrophob
interact
adhes
fig
review
ref
inde
pesti
possess
homolog
tad
cluster
actinomycetemcomitan
confer
hydrophob
bind
properti
although
function
pesti
determin
polymer
compound
polymer
natur
glycoconjug
structur
automat
lend
multival
structur
contain
saccharid
moieti
specif
microbi
adhesin
exampl
heparin
heparan
sulphat
chondroitin
sulphat
compon
extracellular
matrix
commonli
use
pathogen
host
attach
colonis
specif
plantderiv
polysaccharid
inhibit
attach
h
pylori
human
gastric
mucosa
section
activ
compound
deriv
okra
acid
rhamnogalacturonan
liquoric
root
pectic
polym
blackcurr
seed
arabinogalactan
bladderwrack
sulphat
fucoidan
okra
extract
also
reduc
attach
campylobact
jejuni
porphyromona
gingivali
chicken
colon
mucosa
rat
oesophag
tissu
respect
increas
activ
relat
acid
polysaccharid
promot
electrostat
interact
carbohydr
polym
microbi
adhesin
howev
action
larg
polymer
saccharid
appear
predominantli
nonspecif
without
depend
surfac
charg
dextran
dextran
sulphat
glycogen
mannan
inhibit
attach
cell
line
rang
respiratori
pathogen
includ
p
aeruginosa
group
streptococci
staphylococcu
aureu
l
pneumophila
haemophilu
influenza
biothreat
agent
dextran
compos
poli
glucos
chain
bind
bacteria
eukaryot
cell
line
impli
lack
specif
microbi
adhesin
proanthocyanidin
relat
plantderiv
extract
proanthocyanidin
compris
rang
polymer
phenol
chain
flavonoid
catechin
connect
aor
btype
linkag
variou
plant
extract
demonstr
contain
proanthocyanidin
includ
grape
appl
cinnamon
black
currant
green
tea
choke
berri
cranberri
certain
proanthocyanidin
link
divers
health
effect
includ
reduc
risk
coronari
diseas
antioxid
anticanc
antiadhes
activ
cranberri
juic
histor
activ
reduc
incid
urinari
tract
infect
activ
due
presenc
atyp
proanthocyanidin
interact
fimbrial
adhesin
uropathogen
bacteria
e
coli
prevent
access
linkag
present
uroepitheli
cell
proanthocyanidin
cranberri
